Jerzy Wojnar

New approaches and procedures for cancer treatment: Current perspectives

Eltrombopag for the Treatment of Refractory Pure RBC Aplasia after Major ABO Incompatible Hematopoietic Stem Cell Transplantation

Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective

Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American Society for Apheresis

Chronic inflammation in the etiology of disease across the life span

Biodegradable luminescent porous silicon nanoparticles for in vivo applications

Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

Toxic Mechanisms of Five Heavy Metals: Mercury, Lead, Chromium, Cadmium, and Arsenic

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

Outcomes after major or bidirectional ABO‐mismatched allogeneic hematopoietic progenitor cell transplantation after pretransplant isoagglutinin reduction with donor‐type secretor plasma with or without plasma exchange

Red blood cell-incompatible allogeneic hematopoietic progenitor cell transplantation

Gut microbiome and health: mechanistic insights

Cancer-associated cachexia

Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer

Inflammation and tumor progression: signaling pathways and targeted intervention

Doxil® — The first FDA-approved nano-drug: Lessons learned

Anthracycline-induced cardiotoxicity: Overview of studies examining the roles of oxidative stress and free cellular iron

Rediscovering Beta-2 Microglobulin As a Biomarker across the Spectrum of Kidney Diseases

How do I approach ABO‐incompatible hematopoietic progenitor cell transplantation? (CME)

Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis

Preservation of Fertility in Patients with Cancer

Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

Immunogenic cell death and DAMPs in cancer therapy

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

Meta-analysis: Effect of Prophylactic Hematopoietic Colony-Stimulating Factors on Mortality and Outcomes of Infection

Anthracyclines suppress pheochromocytoma cell characteristics, including metastasis, through inhibition of the hypoxia signaling pathway

Clinical practice guidelines for antimicrobial prophylaxis in surgery

Transforming growth factor-beta1 codon 10 polymorphism is associated with acute GVHD after allogenic BMT in Iranian population.

Acute Myeloid Leukemia

ICRP PUBLICATION 118: ICRP Statement on Tissue Reactions and Early and Late Effects of Radiation in Normal Tissues and Organs — Threshold Doses for Tissue Reactions in a Radiation Protection Context

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

The pathogenesis and treatment of cardiac atrophy in cancer cachexia

Successful treatment of pure red cell aplasia because of ABO major mismatched stem cell transplant

Allogeneic Hematopoietic Stem-Cell Transplantation in Patients With Hematologic Malignancies After Dose-Escalated Treosulfan/Fludarabine Conditioning

Prevention of pure red cell aplasia after major or bidirectional ABO blood group incompatible hematopoietic stem cell transplantation by pretransplant reduction of host anti-donor isoagglutinins

Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems

Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia

Anthraquinones As Pharmacological Tools and Drugs

Hematological Problems in Pediatric Intensive Care

Activating killer immunoglobulin‐like receptor incompatibilities enhance graft‐versus‐host disease and affect survival after allogeneic hematopoietic stem cell transplantation

G-CSF Administered in Time-sequenced Setting During Remission Induction and Consolidation Therapy of Adult Acute Lymphoblastic Leukemia has Beneficial Influence on Early Recovery and Possibly Improves Long-term Outcome: A Randomized Multicenter Study

Homozygosity for human leucocyte antigen‐C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen‐C‐matched unrelated donor haematopoietic stem cell transplantation

Imatinib therapy prior to myeloablative allogeneic stem cell transplantation

Treosulfan and fludarabine low‐toxicity conditioning for allogeneic haematopoietic stem cell transplantation in chronic myeloid leukaemia

Beta-2-Microglobulin Level Predicts Outcome Following Autologous Hematopoietic Stem Cell Transplantation in Patients With Multiple Myeloma

Pure red-cell aplasia following major and bi-directional ABO-incompatible allogeneic stem-cell transplantation: recovery of donor-derived erythropoiesis after long-term treatment using different therapeutic strategies

Assessment of risk factors for mortality in patients with cardiovascular disease and a history of treatment for malignancy

Exenatide modulates tumor–endothelial cell interactions in human ovarian cancer cells

Allogeneic bone marrow transplantation with total body irradiation-based conditioning in acute lymphoblastic leukemia patient with Cochlear implant.

Clinical studies on aclacinomycin A cardiotoxicity in adult patients with acute non lymphoblastic leukaemia.

Successful treatment of pure red cell aplasia with repeated, low doses of rituximab in two patients after ABO-incompatible allogeneic haematopoietic stem cell transplantation for acute myeloid leukaemia.